Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | MMP2 | P08253 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8022524 | 0.94 | SHBG (0.48) | SHBGEPHX1TP53CA12CA1 | |
| Cyclohexane SCHEMBL5321429 | 0.94 | SHBG (0.48) | SHBGEPHX1TP53CA12CA1 | |
| SCHEMBL3335831 | 0.94 | SHBG (0.48) | SHBGEPHX1TP53CA12CA1 | |
| SCHEMBL5412 | 0.94 | SHBG (0.48) | SHBGEPHX1TP53CA12CA1 | |
| SCHEMBL5282 | 0.94 | — | — | |
| SCHEMBL17332300 | 0.94 | SHBG (0.41) | SHBGEPHX1TP53CA12CA1 | |
| SCHEMBL28542817 | 0.94 | SHBG (0.48) | SHBGEPHX1TP53CA12CA1 | |
| SCHEMBL7739164 | 0.94 | SHBG (0.48) | SHBGEPHX1TP53CA12CA1 | |
| SCHEMBL21575869 | 0.94 | SHBG (0.48) | SHBGEPHX1TP53CA12CA1 | |
| SCHEMBL5132 | 0.94 | SHBG (0.48) | SHBGEPHX1TP53CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 261 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110022680-A | Antimicrobial compositions | 弗门尼舍有限公司 | 2019-07-16 | — | — | CN | claimed |
| CN-100390261-C | Compositions comprising photo-labile perfume delivery systems | PROCTER & GAMBLE (US) | 2008-05-28 | — | — | CN | claimed |
| CN-1553948-A | Compositions comprising photo-labile perfume delivery systems | — | 2004-12-08 | — | — | CN | claimed |
| US-20030139312-A1 | Highly concentrated fabric softener compositions and articles containing such compositions | PROCTER & GAMBLE COMPANY, THE | 2003-07-24 | — | — | US | claimed |
| EP-1280882-A1 | HIGHLY CONCENTRATED FABRIC SOFTENER COMPOSITIONS AND ARTICLES CONTAINING SUCH COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2003-02-05 | — | — | EP | claimed |
| US-6500797-B1 | Process for preparing β-ketoester fragrance pro-accords from 1,3-dioxan-4,6-diones | THE PROCTER & GAMBLE COMPANY | 2002-12-31 | — | — | US | claimed |
| WO-2001085892-A1 | HIGHLY CONCENTRATED FABRIC SOFTENER COMPOSITIONS AND ARTICLES CONTAINING SUCH COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2001-11-15 | — | — | WO | claimed |
| CN-1233947-A | Fragrance delivery system | PROCTER & GAMBLE (US) | 1999-11-03 | — | — | CN | claimed |
| CN-1233283-A | Rinse added fabric softening compositions and methods for delivering perfume derivatives | PROCTER & GAMBLE (US) | 1999-10-27 | — | — | CN | claimed |
| US-5445747-A | Containing fabric softener, perfume selected to cover odors | THE PROCTER & GAMBLE COMPANY (US) | 1995-08-29 | — | — | US | claimed |
| CN-117980454-B | Aldehyde composition | 三菱瓦斯化学株式会社 | 2026-05-19 | — | — | CN | disclosed |
| US-12624216-B2 | Method for the production of free-flowing granules | OMYA INTERNATIONAL AG (CH) | 2026-05-12 | — | — | US | disclosed |
| EP-4142675-B1 | GRANULES COMPRISING SURFACE-REACTED CALCIUM CARBONATE AS EXCIPIENT | OMYA INT AG (CH) | 2026-03-25 | — | — | EP | disclosed |
| US-12565471-B2 | Isobutyrate ester compound having carbonate group at alpha-position, and fragrance composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-03-03 | — | — | US | disclosed |
| US-12522781-B2 | Alpha-hydroxyisobutyric acid ester compound and fragrance composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-01-13 | — | — | US | disclosed |
| WO-1998007405-A1 | FRAGRANCE DELIVERY SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 1998-02-26 | — | — | WO | disclosed |
| WO-1998007811-A2 | RINSE ADDED FABRIC SOFTENING COMPOSITIONS AND METHOD OF USE FOR THE DELIVERY OF FRAGRANCE DERIVATIVES | THE PROCTER & GAMBLE COMPANY (US) | 1998-02-26 | — | — | WO | disclosed |
| WO-1998007809-A2 | HARD SURFACE CLEANERS COMPRISING β-KETOESTER PRO-FRAGRANCES | THE PROCTER & GAMBLE COMPANY (US) | 1998-02-26 | — | — | WO | disclosed |
| CN-1161002-A | Composition for reducing malodor impression on inanimate surfaces | PROCTER & GAMBLE (US) | 1997-10-01 | — | — | CN | disclosed |
| CN-1159762-A | Uncomplexed cyclodextrin solutions for odor control or inanimate surface | PROCTER & GAMBLE (US) | 1997-09-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565471-B2 | Isobutyrate ester compound having carbonate group at alpha-position, and fragrance composition | AMY1A, TAS1R1, GABRB1 | SHBG 1730/4885EPHX1 4450/4885TP53 4024/4885 |
| US-12624216-B2 | Method for the production of free-flowing granules | TMCO1, ORAI1, CACNA1G | SHBG 661/4885EPHX1 4722/4885TP53 534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.